Saturday, 31 October 2026European Markets

FOUNTAIN Stock Bullish By 24% In The Last 10 Sessions

Loading stream...

FOUNTAIN (FOU.BR), one of the BEL 20 stocks, had a remarkable performance over a short period, demonstrating a 24% increase in less than two weeks. Starting at EUR1, it swiftly rose to EUR1.24 as of 11:40 EST on Thursday. Interestingly, this upsurge reversed an earlier downward trajectory that distinguished this stock from other members of the same index, which is currently showing an overall gain of 0.073% to EUR3,728.99 after suffering four sessions of depreciation.

The Company's Roots and Operations

Established in 1972, FOUNTAIN S.A. operates from Braine-l'Alleud, Belgium. The company specializes in the renting and selling of machines designed to manufacture hot and cold beverages from grains or freeze-dried products. This includes items such as coffee cartridge machines and other beverage production equipment. Their product offerings extend from coffee and cartridge machines to an array of other beverage producing machinery.

Recent Financial Performance

FOUNTAIN's earnings per share (EPS), an essential performance metric, currently stands at EUR-0.15 for the previous twelve months. A negative EPS suggests that the company was unable to generate profits during this time span.

Stock Volatility and Potential Risks

Examining the stock's volatility, an indicator of price fluctuation, is vital for making educated investment decisions. FOUNTAIN's average intraday variation over the past week, month, and quarter was 2.52%. During this same interval, the company's highest volatility amplitudes were 2.52% for the last week, 4.75% for the last month, and 7.53% for its entire history according to this measure.

Consequently, FOUNTAIN may offer the possibility of higher returns. However, this elevated volatility might also heighten the risk levels, thus creating an investment option that may be both rewarding and hazardous. When making investment decisions, it may be advantageous to consider these metrics within the broader framework of your investment strategies and objectives.

More news about FOUNTAIN (FOU.BR).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com